ALCON NORDIC A/S: Financial statements 2015
CVR: 15887478
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
ALCON NORDIC A/S (CVR 15887478) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 1,115,732,000 and a net result of DKK 26,130,000 compared with DKK 21,995,000 the year before. The profit margin was 2.3%. Equity in the 2015 report amounted to DKK 66,212,000. The solvency ratio was 20.2%. The company had 95 employees in the financial year.
- Revenue
- DKK 1,115,732,000
- Gross Profit
- DKK 189,883,000
- Profit/Loss
- DKK 26,130,000
- Equity
- DKK 66,212,000
- Total Assets
- DKK 327,616,000
- Employees
- 95
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 1.1B | 189.9M | 26.1M | 66.2M | 95 |
| 2014 | - | 197.6M | 22M | 40.1M | 49 |
| 2013 | - | 101.8M | 8.7M | 13.8M | 32 |
| 2012 | - | 50.7M | 4.3M | 15.1M | 49 |
Official annual report
How creditworthy is ALCON NORDIC A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 30, 2015, Knut Ulrich Mager has joined the board of directors of ALCON NORDIC A/S.
As of November 30, 2015, Sue Webb has left the board of directors of ALCON NORDIC A/S.
ALCON NORDIC A/S has published its annual report for 2014. Gross profit came to DKK 197,612,000, and the net result was DKK 21,995,000.
As of April 1, 2015, Jorge Horacio Boldrini is registered as adm. dir. of ALCON NORDIC A/S.
As of March 31, 2015, Kristofer Per Vilhelm Karlsson has stepped down as adm. dir. of ALCON NORDIC A/S.
About ALCON NORDIC A/S
ALCON NORDIC A/S is a Danish company of the type Aktieselskab based in København S, founded in 1992. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named ALCON DANMARK A/S and ALCON DANMARK ApS. The management consists of Petr Kotelnikov. The board consists of Julien Rosentraub (chair), Petr Kotelnikov and Umut Meric. The company is owned by Alcon Pharmaceuticals Ltd. The company has 75 employees (2026). In 2025, the company reported revenue of DKK 1,060,222,000 and a net result of DKK 42,026,000 compared with DKK 34,391,000 the year before. Equity in the 2025 report amounted to DKK 171,120,000.